20 IPOs this past May raised $4.3 billion in proceeds, just one IPO short of the 21 in May 2014. Year-to-date, 69 companies have gone public in 2015, a 40%...read more
14 companies were scheduled to go public this week, including 10 health care deals. Only 8 IPOs got through, as 3 biotechs have been pushed back to next week, two companies postponed and one withdrew. however; IPO investors had plenty of options while the NASDAQ...read more
aTyr Pharma, which is developing a new class of protein therapeutics for rare muscular dystrophies, raised $75 million by offering 5.4 million shares at $14, the midpoint of the range of $13 to $15. aTyr Pharma plans to list on the NASDAQ under the symbol LIFE...read more
This could be the busiest 5-day stretch in the IPO market since the week of July 28, 2014, as 14 companies look to raise nearly $2 billion. However, ...read more
May was a big month for IPOs; what does June have in store?
20 IPOs this past May raised $4.3 billion in proceeds, just one IPO short of the 21 in May 2014. Year-to-date, 69 companies have gone public in 2015, a 40%...read more
US IPO Weekly Recap: With 8 IPOs it's Bo-Time for Bojangles and no time for biotechs
14 companies were scheduled to go public this week, including 10 health care deals. Only 8 IPOs got through, as 3 biotechs have been pushed back to next week, two companies postponed and one withdrew. however; IPO investors had plenty of options while the NASDAQ...read more
aTyr Pharma prices IPO at the $14 midpoint
aTyr Pharma, which is developing a new class of protein therapeutics for rare muscular dystrophies, raised $75 million by offering 5.4 million shares at $14, the midpoint of the range of $13 to $15. aTyr Pharma plans to list on the NASDAQ under the symbol LIFE...read more
Week ahead: 14 IPOs planned for the week of May 4
This could be the busiest 5-day stretch in the IPO market since the week of July 28, 2014, as 14 companies look to raise nearly $2 billion. However, ...read more